(Q35548710)

8 August 2017

1 reference

title

Mismatch repair and response to DNA-damaging antitumour therapies (English)

1 reference

8 August 2017

1 reference

Bignami M

1

1 reference

8 August 2017

Casorelli I

series ordinal

2

1 reference

8 August 2017

Karran P

series ordinal

3

1 reference

8 August 2017

publication date

1 October 2003

1 reference

European Journal of Cancer

8 August 2017

published in

1 reference

8 August 2017

volume

39

1 reference

8 August 2017

issue

15

1 reference

8 August 2017

page(s)

2142-2149

1 reference

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Mismatch repair in correction of replication errors and processing of DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Mouse models for human DNA mismatch-repair gene defects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

DNA repair defects in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Transfer of the MSH2.MSH6 complex from proliferating cell nuclear antigen to mispaired bases in DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Human exonuclease I is required for 5' and 3' mismatch repair

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Meiotic arrest and aneuploidy in MLH3-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Mismatch repair defects in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

DNA mismatch repair gene mutations in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Unmasking a killer: DNA O(6)-methylguanine and the cytotoxicity of methylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Signaling mismatch repair in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Involvement of the mismatch repair system in temozolomide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Methylation-induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Mismatch repair proficiency and in vitro response to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Better survival rates in patients with MLH1-associated hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Survival analysis in families affected by hereditary non-polyposis colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Evidence for an age-related influence of microsatellite instability on colorectal cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Source of unique tumour antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Deficient DNA mismatch repair: a common etiologic factor for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Resistance to topoisomerase poisons due to loss of DNA mismatch repair

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Mismatch repair defects as a cause of resistance to cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Rarity of microsatellite alterations in acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Down-regulation of DNA repair in human CD34(+) progenitor cells corresponds to increased drug sensitivity and apoptotic response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

Human MRE11 is inactivated in mismatch repair-deficient cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

The mismatch repair system is required for S-phase checkpoint activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900569-0

7 January 2021

10.1016/S0959-8049(03)00569-0

Identifiers

DOI

1 reference

8 August 2017

1 reference